首页 / 产品目录 / 药典杂质 / Cefuroxime sodium GSK ring opening / Cefuroxime sodium GSK ring opening impurity

Cefuroxime sodium GSK ring opening impurity

CAS 货号 RA-C013001 合成中

Cefuroxime sodium GSK ring opening 的药典杂质对照品, 经 HPLC、质谱与 1H NMR 表征,随批出具证书。

分子式C15H18N4O7S
分子量398.39 g/mol
可选包装5 mg, 10 mg, 25 mg
随附文件COA · SDS · spec sheet
储存条件See certificate

本站不公开价格:包装、文件与运输在同一份报价中确认。

Chemical structure of Cefuroxime sodium GSK ring opening impurity, CAS

本条目说明

Cefuroxime sodium GSK ring opening impurity (CAS ) is supplied as a pure organic reference material under ISO 17034:2016 (ANAB, AR-2832). Each lot is weighed, dispensed and released against a specification that includes identity by mass spectrometry and 1H NMR, and purity by HPLC.

典型用途

Related-substance method development and validation, identification of impurity peaks in Cefuroxime sodium GSK ring opening drug substance, system suitability, and quantitative calibration where a defined reference is required.

运输与储存

Shipped worldwide with the SDS and, where applicable, a non-hazardous declaration. Cold-chain and dry ice are used when the material requires it; the storage condition and retest date are stated on the lot certificate rather than assumed from the catalogue.

Identifiers: catalogue RA-C013001 · CAS · formula C15H18N4O7S · 分子量 398.39. If you need a different pack size or a co-lot certificate, ask — both are routine.

Other standards for this drug substance